Catalyst Wire Dossier Catalyst Wire Dossier

Rebetol

ribavirin
Drug timelines are a Plus or Pro feature.

38 regulatory and trial events tracked for Rebetol, covering 2008-12-11 to 2023-11-07. Get the full timeline:

Most recent: EMA Withdrawn: Rebetol (ribavirin) — Merck Sharp and Dohme B.V

See pricing